Literature DB >> 16499032

[Effect of glucocorticoid with traditional Chinese medicine in severe acute aespiratory syndrome (SARS)].

Bao-yan Liu1, Li-yun He, Zhi-wei Liang, Xin-yuan Tong, Jing-qing Hu, Qiang Jiao, Qing Ni, Xi-ming Liu, Yan-ming Xie, Ping Li, Fan-zhu Gao, Tian-cai Wen, Wei-min Liu.   

Abstract

OBJECTIVE: To evaluate the effects of traditional Chinese medicine in 461 cases of severe acute respiratory syndrome(SARS) on glucocorticoid's dosage.
METHOD: By using the polycentric nonrandomized concurrent controled trial and under the condition of glucocorticoid use, the patierts were divided into two groups: the integrated traditional Chinese and western mendicine(ITCWM) and simplicity western mendicine alone(WM). The observation indexes were time in hospital, pneumonia duration, mortality, glucocorticoid's gross dosage, glucocorticoid's average dosage of days and glucocorticoid use time. RESULT: In the ITCWM group, average time in hospital was shortened (P = 0.058), pneumonia duration was shortened (P = 0.057), mortality fell (P = -0.001). The median of glucocorticoid' s gross dosage was 1,277.0 mg x d(-1) in the ITCWM group, and that was 1,680.0 mg x d(-1) in the WM group (P = 0.083). The median of glucocorticoid's average dosage of days was 84.40 mg x d(-1) in the ITCWM group, and that was 115.33 mg x d(-1) in the WM group (P = 0.025). According to the analysis of 461 cases divided by stages and different ponderance, within 7 days after illness, in the ITCWM group, the glucocorticoid' s average dosage decreased. In the common type, the dosage in the ITCWM and in the WM was 146.43 mg x d(-1), and 183.64 mg x d(-1), respectively (P = 0.057), in the severe type, that was 137.71 and 177.86 mg x d(-1), respectively (P = 0.001).
CONCLUSION: Compared with the group of simplicity western mendicine, in the group of integratived Chinese and western mendicine, time in hospital shorten, pneumonia duration shorten, mortality fall, simultaneity, glucocorticoid's average dosage is decreased. The use of TCM in the forepart of treatment can be capable of decreasing glucocorticoid's dosage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16499032

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  8 in total

1.  The long-term consequences of Corona Virus Disease 2019 patients receiving Chinese herbal medicine treatments in acute phase: A protocol for systematic review and meta-analysis.

Authors:  Yi-Ming Sun; Jia-Yan Liu; Ran Sun; Jie Zhang; Meng-Lu Xiao; Gui-Ping Li
Journal:  Medicine (Baltimore)       Date:  2021-07-23       Impact factor: 1.817

Review 2.  Traditional Chinese medicine for treatment of liver diseases: progress, challenges and opportunities.

Authors:  Chang-qing Zhao; Yang Zhou; Jian Ping; Lie-ming Xu
Journal:  J Integr Med       Date:  2014-09

3.  Prevalence and associated factors of complementary and integrative medicine use in patients afflicted with COVID-19.

Authors:  Mohammad Mahdi Parvizi; Sedigheh Forouhari; Reza Shahriarirad; Sepehr Shahriarirad; Ryan D Bradley; Leila Roosta
Journal:  BMC Complement Med Ther       Date:  2022-09-30

4.  Efficacy of Traditional Chinese Medicine on COVID-19: Two Case Reports.

Authors:  Zi Zhou Zheng; Ning Ning Ma; Lily Li; Dan Jiang
Journal:  Med Acupunct       Date:  2021-02-16

5.  Novel Coronavirus Pneumonia Treatment With Traditional Chinese Medicine: Response Philosophy in Another Culture.

Authors:  Zhuman Li; Chuangchuang Han; Huihong Huang; Zhijun Guo; Feng Xu
Journal:  Front Public Health       Date:  2020-07-10

6.  Traditional Chinese herbal medicine for treating novel coronavirus (COVID-19) pneumonia: protocol for a systematic review and meta-analysis.

Authors:  Yuxi Li; Xiaobo Liu; Liuxue Guo; Juan Li; Dongling Zhong; Yonggang Zhang; Mike Clarke; Rongjiang Jin
Journal:  Syst Rev       Date:  2020-04-08

Review 7.  Differences in the origin of philosophy between Chinese medicine and Western medicine: Exploration of the holistic advantages of Chinese medicine.

Authors:  Da-zhi Sun; Shao-dan Li; Yi Liu; Yin Zhang; Rong Mei; Ming-hui Yang
Journal:  Chin J Integr Med       Date:  2013-08-24       Impact factor: 1.978

Review 8.  Phytogenic Products and Phytochemicals as a Candidate Strategy to Improve Tolerance to Coronavirus.

Authors:  Youssef A Attia; Mahmoud M Alagawany; Mayada R Farag; Fatmah M Alkhatib; Asmaa F Khafaga; Abdel-Moneim Eid Abdel-Moneim; Khalid A Asiry; Noura M Mesalam; Manal E Shafi; Mohammed A Al-Harthi; Mohamed E Abd El-Hack
Journal:  Front Vet Sci       Date:  2020-10-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.